C57BL/6JCya-Dcnem1flox/Cya
Common Name
Dcn-flox
Product ID
S-CKO-02007
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-13179-Dcn-B6J-VA
When using this mouse strain in a publication, please cite “Dcn-flox Mouse (Catalog S-CKO-02007) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Dcn-flox
Strain ID
CKOCMP-13179-Dcn-B6J-VA
Gene Name
Product ID
S-CKO-02007
Gene Alias
DC, PG40, PGII, PGS2, DSPG2, SLRR1B
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 10
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000105287
NCBI RefSeq
NM_001190451
Target Region
Exon 3
Size of Effective Region
~1.7 kb
Overview of Gene Research
Dcn, short for Decorin, is a member of the small leucine-rich proteoglycan gene family. It is secreted from stromal fibroblasts and has non-cell-autonomous anti-cancer effects. Dcn is involved in multiple biological processes, such as regulating the extracellular matrix. It may interact with various signaling pathways like IL-6/STAT3/AUF1, TGF-β1/SMAD3, and is important in immune responses, cancer development, and tissue fibrosis [1,2].
In breast stromal fibroblasts, DCN down-regulation activates these cells and promotes their pro-carcinogenic effects through the IL-6/STAT3/AUF1 signaling. DCN-deficient fibroblasts enhance angiogenesis, orthotopic tumor growth, and increase the resistance of breast cancer cells to cisplatin [1]. In renal cell carcinoma, DCN acts as a tumor suppressor. DCN overexpression inhibits cell proliferation and metastasis both in vitro and in vivo by upregulating P21 and E-cadherin [4]. In corneal fibrosis and neovascularization, AAV5-DCN gene therapy can effectively reduce these conditions in rabbit eyes [3].
In conclusion, Dcn plays crucial roles in cancer and tissue-related diseases. Studies on Dcn, especially through in vivo models, have revealed its anti-carcinogenic and anti-fibrotic properties, providing potential therapeutic targets for breast cancer, renal cell carcinoma, and corneal diseases.
References：
1. Aljagthmi, Wafaa A, Alasmari, Manal A, Daghestani, Maha H, Al-Mohanna, Falah H, Aboussekhra, Abdelilah. 2024. Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling. In Cells, 13, . doi:10.3390/cells13080680. https://pubmed.ncbi.nlm.nih.gov/38667295/
2. Wang, Shanxi, Qu, Yunkun, Fang, Xuan, Wu, Hua, Liu, Yang. 2023. Decorin: a potential therapeutic candidate for ligamentum flavum hypertrophy by antagonizing TGF-β1. In Experimental & molecular medicine, 55, 1413-1423. doi:10.1038/s12276-023-01023-y. https://pubmed.ncbi.nlm.nih.gov/37394592/
3. Mohan, Rajiv R, Gupta, Suneel, Kumar, Rajnish, Chaurasia, Shyam S, Hesemann, Nathan P. 2024. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo. In The ocular surface, 32, 13-25. doi:10.1016/j.jtos.2024.01.001. https://pubmed.ncbi.nlm.nih.gov/38191093/
4. Xu, Yongcan, Xia, Qiuyuan, Rao, Qiu, Chen, Hui, Zhou, Xiaojun. 2015. DCN deficiency promotes renal cell carcinoma growth and metastasis through downregulation of P21 and E-cadherin. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 5171-83. doi:10.1007/s13277-015-4160-1. https://pubmed.ncbi.nlm.nih.gov/26547587/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.